Robert Besthof is a 25+ years global pharmaceutical hands-on strategic and operational leader with a track record of building pipelines and globally launching products.  He worked for Eli Lilly, Wyeth and Pfizer across multiple strategic and operational senior leader roles.  His big pharma assignments included various in-country P&L assignments launching and growing products, strategic marketing and product development.  In 2016, he established his consultancy focused on emerging biotechnology companies, assuming leadership positions and working with his clients to define and implement investable paths for preclinical and clinical programs.  He has built and led teams that generated a combined 18 proof of concept and phase III programs across multiple therapeutic areas.  His assignments have included Commercial Assessment, Business Development and Licensing, Head of Operations, and interim CEO of a public company.  Robert received a B.A. in economics from Case Western Reserve University in Cleveland and a Masters of International Management from the Thunderbird School of Management in Glendale.  Robert speaks fluent German, Spanish and Dutch, and is conversant in other languages.